Why it's important that Moderna, Pfizer included Black, Latinx and older participants in COVID-19 vaccine trials

Drugmaker Moderna is being hailed for its efforts to include participants who are most at risk for COVID-19 — namely, people of color, older people and those with preexisting conditions — in its vaccine trials, which show a 94.5 percent efficacy rate against the virus.